Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of Transcriptomics to Reveal the Joint Immunotoxicity Mechanism Initiated by Difenoconazole and Chlorothalonil in the Human Jurkat T-Cell Line. | Foods | 2023 | 38201063 | PubTator, text mining | PubMed |
| CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1. | Breast Cancer (Dove Med Press) | 2023 | 38164371 | PubTator, text mining | PubMed |
| Targeting the immune microenvironment for ovarian cancer therapy. | Front Immunol | 2023 | 38164130 | PubTator, text mining | PubMed |
| Elucidating the Influence of MPT-driven necrosis-linked LncRNAs on immunotherapy outcomes, sensitivity to chemotherapy, and mechanisms of cell death in clear cell renal carcinoma. | Front Oncol | 2023 | 38162499 | PubTator, text mining | PubMed |
| Comprehensively prognostic and immunological analysis of VRK Serine/Threonine Kinase 1 in pan-cancer and identification in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 38157278 | PubTator, text mining | PubMed |
| A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors. | Front Immunol | 2023 | 38152397 | PubTator, text mining | PubMed |
| VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature. | Open Med (Wars) | 2023 | 38152334 | PubTator, text mining | PubMed |
| Alternative immune checkpoints in immunoregulatory profile of cancer stem cells. | Heliyon | 2023 | 38144305 | PubTator, text mining | PubMed |
| Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α. | Int J Mol Sci | 2023 | 38138998 | PubTator, text mining | PubMed |
| Glycyrrhizinic Acid as an Antiviral and Anticancer Agent in the Treatment of Human Papillomavirus. | J Pers Med | 2023 | 38138866 | PubTator, text mining | PubMed |
| Identification of Central Nervous System Oncologic Disease Biomarkers in EVs from Cerebrospinal Fluid (CSF) of Pediatric Patients: A Pilot Neuro-Proteomic Study. | Biomolecules | 2023 | 38136601 | PubTator, text mining | PubMed |
| Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data. | PLoS One | 2023 | 38127899 | PubTator, text mining | PubMed |
| Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy. | Front Pharmacol | 2023 | 38116078 | PubTator, text mining | PubMed |
| Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells. | Asia Pac Allergy | 2023 | 38094089 | PubTator, text mining | PubMed |
| Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis. | Front Immunol | 2023 | 38077334 | PubTator, text mining | PubMed |
| Immune checkpoints in rheumatoid arthritis: progress and promise. | Front Immunol | 2023 | 38077329 | PubTator, text mining | PubMed |
| Flying under the radar - impact and factors influencing asymptomatic DENV infections. | Front Cell Infect Microbiol | 2023 | 38076464 | PubTator, text mining | PubMed |
| Immune checkpoint status and exhaustion-related phenotypes of CD8+ T cells from the tumor-draining regional lymph nodes in breast cancer. | Cancer Med | 2023 | 38069525 | PubTator, text mining | PubMed |
| Sitagliptin Induces Tolerogenic Human Dendritic Cells. | Int J Mol Sci | 2023 | 38069152 | PubTator, text mining | PubMed |
| Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor. | Cancers (Basel) | 2023 | 38067332 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=9